Monday, April 20, 2015

Adjuvant Ipilimumab effects survival after high risk lymph node and melanoma resection

Adjuvant Ipilimumab significantly improves recurrence-free survival in patients with completely resected stage III melanoma at high risk of disease recurrence, research indicates, but that this treatment was also associated with a high rate of immune-related adverse events.



from Top Health News – ScienceDaily http://bit.ly/1zD2bZQ via Naturally Increase Breast Size At Home
from Tumblr http://bit.ly/1E31ApP

No comments:

Post a Comment